Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Axogen Inc has a consensus price target of $19.82 based on the ratings of 11 analysts. The high is $30 issued by Lake Street on March 17, 2025. The low is $9 issued by Leerink Partners on October 16, 2023. The 3 most-recent analyst ratings were released by Canaccord Genuity, Lake Street, and Cantor Fitzgerald on May 13, 2025, March 17, 2025, and March 5, 2025, respectively. With an average price target of $26 between Canaccord Genuity, Lake Street, and Cantor Fitzgerald, there's an implied 182.00% upside for Axogen Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/13/2025 | Buy Now | 160.3% | Canaccord Genuity | Caitlin Cronin36% | $26 → $24 | Maintains | Buy | Get Alert |
03/17/2025 | Buy Now | 225.38% | Lake Street | Frank Takkinen36% | → $30 | Initiates | → Buy | Get Alert |
03/05/2025 | Buy Now | 160.3% | Cantor Fitzgerald | Ross Osborn44% | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
03/05/2025 | Buy Now | 182% | Citizens Capital Markets | David Turkaly50% | $26 → $26 | Reiterates | Market Outperform → Market Outperform | Get Alert |
02/26/2025 | Buy Now | 182% | Canaccord Genuity | Caitlin Cronin36% | $22 → $26 | Maintains | Buy | Get Alert |
02/26/2025 | Buy Now | 182% | Citizens Capital Markets | Constantine Davides41% | $20 → $26 | Maintains | Market Outperform | Get Alert |
02/03/2025 | Buy Now | 138.61% | Canaccord Genuity | Caitlin Cronin36% | $18 → $22 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | 84.38% | Canaccord Genuity | Caitlin Cronin36% | $15 → $17 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | 116.92% | JMP Securities | David Turkaly50% | $17 → $20 | Maintains | Market Outperform | Get Alert |
07/01/2024 | Buy Now | 41% | Raymond James | Jayson Bedford68% | → $13 | Initiates | → Outperform | Get Alert |
06/20/2024 | Buy Now | 62.69% | Canaccord Genuity | Caitlin Cronin36% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
01/19/2024 | Buy Now | 30.15% | Cantor Fitzgerald | Ross Osborn44% | $12 → $12 | Reiterates | Overweight → Overweight | Get Alert |
12/07/2023 | Buy Now | 19.31% | Canaccord Genuity | Caitlin Cronin36% | $15 → $11 | Reiterates | Buy → Buy | Get Alert |
10/16/2023 | Buy Now | -2.39% | Leerink Partners | Mike Kratky67% | → $9 | Initiates | → Outperform | Get Alert |
09/26/2023 | Buy Now | 73.54% | Cantor Fitzgerald | Ross Osborn44% | → $16 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | Buy Now | 73.54% | Cantor Fitzgerald | Travis Steed57% | → $16 | Reiterates | Overweight → Overweight | Get Alert |
05/10/2023 | Buy Now | 116.92% | JMP Securities | David Turkaly50% | → $20 | Reiterates | → Market Outperform | Get Alert |
03/28/2023 | Buy Now | 62.69% | Canaccord Genuity | Kyle Rose68% | $15 → $15 | Reiterates | → Buy | Get Alert |
03/15/2023 | Buy Now | 116.92% | JMP Securities | David Turkaly50% | → $20 | Reiterates | → Market Outperform | Get Alert |
11/11/2022 | Buy Now | 62.69% | Jefferies | Michael Sarcone9% | → $15 | Assumes | → Buy | Get Alert |
The latest price target for Axogen (NASDAQ:AXGN) was reported by Canaccord Genuity on May 13, 2025. The analyst firm set a price target for $24.00 expecting AXGN to rise to within 12 months (a possible 160.30% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Axogen (NASDAQ:AXGN) was provided by Canaccord Genuity, and Axogen maintained their buy rating.
There is no last upgrade for Axogen
There is no last downgrade for Axogen.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a maintained with a price target of $26.00 to $24.00. The current price Axogen (AXGN) is trading at is $9.22, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.